Article
Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI.
Journal of neurotrauma - 15 Aug 2013
Garringer Julie A, Niyonkuru Christian, McCullough Emily H, Loucks Tammy, Dixon C Edward, Conley Yvette P, Berga Sarah, Wagner Amy K
Abstract excerpt
Although experimental traumatic brain injury (TBI) studies support estradiol as a neuroprotectant and potent stimulator of neuroplasticity, clinical studies suggest a negative association between endogenous estradiol profiles and mortality/poor outcomes. However, no studies have evaluated associations with cerebral spinal fluid (CSF) hormone profiles and aromatase gene (cytochrome P450 [CYP]19A1) variability on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
